Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study
- PMID: 15701108
- DOI: 10.1111/j.1600-0447.2004.00451.x
Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study
Abstract
Objective: The European Schizophrenia Out-patient Health Outcomes study is an observational study investigating treatment in schizophrenia. We report treatment-emergent adverse events during the first 6 months of treatment.
Method: The rate of extrapyramidal symptoms (EPS), anticholinergic use, weight gain and sexual related dysfunctions were assessed in 8,400 out-patients.
Results: Patients typical antipsychotics and risperidone experienced significantly more EPS and anticholinergic use than patients in the clozapine, olanzapine, and quetiapine cohorts. Patients treated with amisulpride, typical antipsychotics and risperidone were significantly more likely to have sexual related dysfunctions and/or amenorrhea. Increases in weight and body mass index occurred in all cohorts, but were significantly greater in the olanzapine and clozapine cohorts.
Conclusion: Patients treated with olanzapine, quetiapine and clozapine had better tolerability outcomes regarding EPS and sexual related dysfunctions compared with patients receiving risperidone, amisulpride and typicals. Patients treated with olanzapine and clozapine had higher weight increases than patients treated with risperidone, quetiapine and typicals.
Copyright (c) Blackwell Munksgaard 2004
Similar articles
-
Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.J Sex Marital Ther. 2003 Mar-Apr;29(2):125-47. doi: 10.1080/713847170. J Sex Marital Ther. 2003. PMID: 12623765 Clinical Trial.
-
[A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].Neuropsychopharmacol Hung. 2007 Oct;9(3):115-24. Neuropsychopharmacol Hung. 2007. PMID: 18399029 Hungarian.
-
Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.J Clin Psychiatry. 2008 Dec;69(12):1901-15. Epub 2008 Sep 9. J Clin Psychiatry. 2008. PMID: 19012820
-
The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.CNS Drugs. 2006;20(4):293-301. doi: 10.2165/00023210-200620040-00003. CNS Drugs. 2006. PMID: 16599647 Review.
-
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.BMJ. 2000 Dec 2;321(7273):1371-6. doi: 10.1136/bmj.321.7273.1371. BMJ. 2000. PMID: 11099280 Free PMC article. Review.
Cited by
-
A Review of Olanzapine in the Treatment of Cancer Anorexia-Cachexia Syndrome.Pharmacy (Basel). 2024 Feb 17;12(1):34. doi: 10.3390/pharmacy12010034. Pharmacy (Basel). 2024. PMID: 38392941 Free PMC article. Review.
-
The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis.Psychopharmacology (Berl). 2021 Mar;238(3):665-676. doi: 10.1007/s00213-020-05715-5. Epub 2020 Nov 23. Psychopharmacology (Berl). 2021. PMID: 33230696
-
Clinical Pharmacokinetics of Atypical Antipsychotics: An Update.Clin Pharmacokinet. 2018 Dec;57(12):1493-1528. doi: 10.1007/s40262-018-0664-3. Clin Pharmacokinet. 2018. PMID: 29915922 Review.
-
Schizophrenia Outpatient Health Outcomes study: twelve-month findings.Pragmat Obs Res. 2012 Jun 6;3:27-40. doi: 10.2147/POR.S26552. eCollection 2012. Pragmat Obs Res. 2012. PMID: 27774015 Free PMC article.
-
Clinical pharmacology of atypical antipsychotics: an update.EXCLI J. 2014 Oct 13;13:1163-91. eCollection 2014. EXCLI J. 2014. PMID: 26417330 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical